Professional Documents
Culture Documents
Introduction
Definitions
– Permanent cessation of menstrual periods due to declining
estrogen and progesterone production by the ovaries, i.e.
cessation of ovarian function.
– Lab. Defn = presence of signs of hypoestrogenemia and serum
FSH level of >40 IU/L (N=5-10IU/L).
– Refers to the final menstrual period (cycle)
FSH:-
• Serum FSH levels begin to rise.
• The early evidence of change in ovarian function
• Elevated 10-20X,
• Level >40 IU is consistent with complete cessation of ovarian
function
Hormonal changes contd.
• LH:-
– Rise only by 2-3 fold.
• Estrogens:-
– Origin = 90% ovary, 10% adrenal & peripheral
• Secretion markedly decreases in post menopause
• Main source becomes peripheral conversion of androgens.
– Mainly is estrone
Hormonal changes contd.
• Progesterone:-
– 90 % in theca lutein cells of corpus luteum & 10 % in adrenal
cortex.
– Post menopause is only adrenal source
• Androgens:-
– In reproductive age ovary produces 50% androstenendione
and 25% testosterone
– Although the total level of androgens drops after menopause,
there is relative increase in androgenesity.
Menopause-related Symptoms
Vasomotor Genitourniary Other Systemic
Headache Vaginal dryness Fatigue
Palpitations Dyspareunia Reduced sexual
desire/arousal
Night sweats Vaginal
Insomnia/sleep itching/burning Anxiety, irritability
disturbance Urinary and depression
frequency, Cognitive
dysuria, urgency difficulties
Backache/
stiffness
Hot Flashes
• Definition:
• Sudden onset of reddening of the skin of head, neck, chest,
intense body heat, rapid heart rate, followed by perspiration
and chilling .
• Cause:
• vasomotor instability triggered by hormonal changes
• Significance:
• Affect 30 to 85% women, incapacitating in 10%
• Has no inherent health hazard.
• Significant effect on sleep, mood, and cognitive function
• Typically begin to decrease within 2 years after last period,
Pathophysiology
• Sexual Dysfunction
– Most women with changes in sexual function after
menopause report lower sexual satisfaction with their
partner after menopause.
– estrogen therapy increases libido in 50% of women with
sexual dysfunction
Indications & benefits of HRT
A. Treatment of perimenapausal symptoms.
i. Hot flush (vasomotor instability):-
The most common symptom and indication for HRT
80-100% reduction with ERT.
ii. Atrophic changes:-
Vaginal mucosal atrophies vaginitis, dyspareunia & stenosis.
Genitourinery atrophies uretritis, recurrent UTI
Atrophic skin changes. -ERT better skin quality
iii. Affective symptoms.
Depression ,insomnia, irritability, & loss of concentration.
Direct or indirect effects.
iv. Loss of libido:-
A direct or indirect effect.
HRT
HRT contd.
B. Protection of cardiovascular diseases
• Decreases risk of MI & stroke by ~50%.
• A favorable impact on lipids & lipoproteins.
C. Effect against osteoporosis
• Especially indicated in smokers, family history, low body wt , x-ray
evidence & premature menopause.
• Decreases bone loss & gain bone density
Risks & S/E of HRT
• Breast Ca.
• Endometrial hyperplasia & ca. :-
1yr unopposed 20-50% hyperplasia
A common reason for avoiding HRT by women.
• Weight gain & water retention.
• Stroke, thromboembolism
• Progestational side effects :-
Breast tenderness , bloating, depression, anxiety, irritability.
• Venous thrombosis:-
The actual risk is very low & limited to first year oral HRT.
• Ovarian ca.
CONTRAINDICATIONS
A. Absolute B. Relative
1.Conditions related to estrogen High serum triglycerides.
exposure: Seizure disorders
Active thromboembolic
event. Current gallbladder disease.
Endometrial Ca. Migraine headache.
Breast Ca. Poorly controlled
Undiagnosed AUB. hypertension
2.Related to estrogen metabolism:-
Active hepatic disease.
Chronically impaired liver
function.
.
Alternative managements
Methods:-
Life style modification:- Physical activity, Avoid smoking,
Avoid excessive alcohol, Avoid high coffee
Calcium supplementation(1000mg/day), 1 cup milk = 300mg
vitamin D
THANK YOU!
Assignment